Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cue Health Inc. stock in Canada

Own Cue Health Inc. shares in just a few minutes.

Cue Health Inc. is a health information services business based in the US. Cue Health Inc. stocks (HLTH.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $9.79 – an increase of 4% over the previous week. Cue Health Inc. employs 1,290 staff and has a trailing 12-month revenue of around $438.9 million.

How to buy shares in Cue Health Inc.

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HLTH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy Cue Health Inc. stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Cue Health Inc. stock price (NASDAQ: HLTH)

Use our graph to track the performance of HLTH stocks over time.

Cue Health Inc. shares at a glance

Information last updated 2021-11-24.
Latest market close$11.45
52-week range$8.53 - $22.55
50-day moving average $11.10
200-day moving average $11.10
Wall St. target price$15.25
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.51

Compare online trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Feature Table description
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks (total value up to $9,000) when you deposit and trade $150.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
OFFER
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of at least $200/month. Valid until March 1, 2022.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.
loading

Compare up to 4 providers

Online stock trading

Cue Health Inc. price performance over time

Historical closes compared with the close of $11.45 from 2021-11-26

1 week (2021-11-19) 4.00%
1 month (2021-10-28) 16.96%
3 months (2021-08-24) N/A
6 months (2021-05-24) N/A
1 year (2020-11-24) N/A
2 years (2019-11-24) N/A
3 years (2018-11-24) N/A
5 years (2016-11-24) N/A

Is Cue Health Inc. under- or over-valued?

Valuing Cue Health Inc. stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cue Health Inc.'s overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Cue Health Inc.'s EBITDA

Cue Health Inc.'s EBITDA (earnings before interest, taxes, depreciation and amortisation) is $183.7 million.

The EBITDA is a measure of a Cue Health Inc.'s overall financial performance and is widely used to measure a its profitability.

Cue Health Inc. financials

Revenue TTM $438.9 million
Operating margin TTM 35.94%
Gross profit TTM $-17,597,000
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 7.44%
Book value $4.47
Market capitalisation $1.4 billion

TTM: trailing 12 months

Cue Health Inc. share dividends

We're not expecting Cue Health Inc. to pay a dividend over the next 12 months.

Cue Health Inc. overview

Cue Health Inc. , a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for public sectors, healthcare providers, large enterprises, and individual consumers. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System comprising a portable and reusable reader (Cue Reader), a single-use test cartridge (Cue Cartridge), and a sample collection wand (Cue Wand); Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows for integrations with third-party applications and sensors. Its diagnostic test for use with Cue Health Monitoring System is Cue COVID-19 Test Kit for ribonucleic acid of SARS-CoV-2, the virus that causes COVID-19. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site